Engineering E. coli for caffeic acid biosynthesis from renewable sugars

Haoran Zhang, Gregory Stephanopoulos

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Caffeic acid is a valuable aromatic compound that possesses many important pharmacological activities. In structure, caffeic acid belongs to the hydroxycinnamic acid family and can be biosynthesized from the aromatic amino acid tyrosine. In the present paper, the caffeic acid biosynthesis pathway was reconstituted in engineered Escherichia coli to produce caffeic acid from simple biomass sugar glucose and xylose. Different engineering approaches were utilized to optimize the production. Specifically, two parallel biosynthesis routes leading from tyrosine to caffeic acid were studied. The copy number of the intermediate biosynthesis genes was varied to find appropriate gene doses for caffeic acid biosynthesis. Three different media, including a MOPS medium, a synthetic medium, and a rich medium, were also examined to improve the production. The highest specific caffeic acid production achieved was 38 mg/L/OD. Lastly, cultivation of engineered E. coli in a bioreactor resulted in a production of 106 mg/L caffeic acid after 4 days.

Original languageEnglish (US)
Pages (from-to)3333-3341
Number of pages9
JournalApplied Microbiology and Biotechnology
Volume97
Issue number8
DOIs
StatePublished - Apr 1 2013

Fingerprint

Escherichia coli
Tyrosine
Coumaric Acids
Aromatic Amino Acids
caffeic acid
Bioreactors
Biomass
Genes
Pharmacology

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Applied Microbiology and Biotechnology

Keywords

  • Caffeic acid
  • Escherichia coli
  • Heterologous biosynthesis
  • Tyrosine

Cite this

@article{abed71700270496c91c2b78ab701f03e,
title = "Engineering E. coli for caffeic acid biosynthesis from renewable sugars",
abstract = "Caffeic acid is a valuable aromatic compound that possesses many important pharmacological activities. In structure, caffeic acid belongs to the hydroxycinnamic acid family and can be biosynthesized from the aromatic amino acid tyrosine. In the present paper, the caffeic acid biosynthesis pathway was reconstituted in engineered Escherichia coli to produce caffeic acid from simple biomass sugar glucose and xylose. Different engineering approaches were utilized to optimize the production. Specifically, two parallel biosynthesis routes leading from tyrosine to caffeic acid were studied. The copy number of the intermediate biosynthesis genes was varied to find appropriate gene doses for caffeic acid biosynthesis. Three different media, including a MOPS medium, a synthetic medium, and a rich medium, were also examined to improve the production. The highest specific caffeic acid production achieved was 38 mg/L/OD. Lastly, cultivation of engineered E. coli in a bioreactor resulted in a production of 106 mg/L caffeic acid after 4 days.",
keywords = "Caffeic acid, Escherichia coli, Heterologous biosynthesis, Tyrosine",
author = "Haoran Zhang and Gregory Stephanopoulos",
year = "2013",
month = "4",
day = "1",
doi = "10.1007/s00253-012-4544-8",
language = "English (US)",
volume = "97",
pages = "3333--3341",
journal = "Applied Microbiology and Biotechnology",
issn = "0175-7598",
publisher = "Springer Verlag",
number = "8",

}

Engineering E. coli for caffeic acid biosynthesis from renewable sugars. / Zhang, Haoran; Stephanopoulos, Gregory.

In: Applied Microbiology and Biotechnology, Vol. 97, No. 8, 01.04.2013, p. 3333-3341.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Engineering E. coli for caffeic acid biosynthesis from renewable sugars

AU - Zhang, Haoran

AU - Stephanopoulos, Gregory

PY - 2013/4/1

Y1 - 2013/4/1

N2 - Caffeic acid is a valuable aromatic compound that possesses many important pharmacological activities. In structure, caffeic acid belongs to the hydroxycinnamic acid family and can be biosynthesized from the aromatic amino acid tyrosine. In the present paper, the caffeic acid biosynthesis pathway was reconstituted in engineered Escherichia coli to produce caffeic acid from simple biomass sugar glucose and xylose. Different engineering approaches were utilized to optimize the production. Specifically, two parallel biosynthesis routes leading from tyrosine to caffeic acid were studied. The copy number of the intermediate biosynthesis genes was varied to find appropriate gene doses for caffeic acid biosynthesis. Three different media, including a MOPS medium, a synthetic medium, and a rich medium, were also examined to improve the production. The highest specific caffeic acid production achieved was 38 mg/L/OD. Lastly, cultivation of engineered E. coli in a bioreactor resulted in a production of 106 mg/L caffeic acid after 4 days.

AB - Caffeic acid is a valuable aromatic compound that possesses many important pharmacological activities. In structure, caffeic acid belongs to the hydroxycinnamic acid family and can be biosynthesized from the aromatic amino acid tyrosine. In the present paper, the caffeic acid biosynthesis pathway was reconstituted in engineered Escherichia coli to produce caffeic acid from simple biomass sugar glucose and xylose. Different engineering approaches were utilized to optimize the production. Specifically, two parallel biosynthesis routes leading from tyrosine to caffeic acid were studied. The copy number of the intermediate biosynthesis genes was varied to find appropriate gene doses for caffeic acid biosynthesis. Three different media, including a MOPS medium, a synthetic medium, and a rich medium, were also examined to improve the production. The highest specific caffeic acid production achieved was 38 mg/L/OD. Lastly, cultivation of engineered E. coli in a bioreactor resulted in a production of 106 mg/L caffeic acid after 4 days.

KW - Caffeic acid

KW - Escherichia coli

KW - Heterologous biosynthesis

KW - Tyrosine

UR - http://www.scopus.com/inward/record.url?scp=84876676603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876676603&partnerID=8YFLogxK

U2 - 10.1007/s00253-012-4544-8

DO - 10.1007/s00253-012-4544-8

M3 - Article

C2 - 23179615

AN - SCOPUS:84876676603

VL - 97

SP - 3333

EP - 3341

JO - Applied Microbiology and Biotechnology

JF - Applied Microbiology and Biotechnology

SN - 0175-7598

IS - 8

ER -